Authors
Vibhudutta Awasthi, Tarun W Dasari, Kenichi A Tanaka
Published in
ACS pharmacology & translational science. Volume 9. Issue 10. Pages 3000-3004. Oct 09, 2026. Epub Sep 17, 2026.
Abstract
Dozens of agents that limit reperfusion injury preclinically have failed clinically. These failures are architectural, not biological: the right biology reaches the wrong place, as the wrong molecule, at the wrong time, judged by the wrong end point. We recast each as a design constraint and specify a staged regimen anchored at first medical contact.
PMID:
42871611
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0